Protalix BioTherapeutics
PLX
#8873
Rank
NZ$0.40 B
Marketcap
NZ$4.98
Share price
0.00%
Change (1 day)
16.32%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): NZ$43.08 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$80.61 Million. In 2025 the company made an earning of -NZ$7.62 Million a decrease over its 2024 earnings that were of NZ$9.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$43.08 M-665.56%
2025 -NZ$7.62 Million-181.6%
2024 NZ$9.33 M-55.62%
2023 NZ$21.03 M-199.05%
2022 -NZ$21.25 Million-40.38%
2021 -NZ$35.63 Million-732.31%
2020 NZ$5.63 M-130.53%
2019 -NZ$18.46 Million189.85%
2018 -NZ$6.37 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$33.14 Million-32.37%
2015 -NZ$49 Million10.11%
2014 -NZ$44.5 Million-7.59%
2013 -NZ$48.15 Million
2011 -NZ$55.76 Million-19.39%
2010 -NZ$69.17 Million20.87%
2009 -NZ$57.23 Million32.26%
2008 -NZ$43.27 Million-5.46%
2007 -NZ$45.77 Million
2004 -NZ$0.3 Million12.35%
2003 -NZ$0.27 Million-11.1%
2002 -NZ$0.3 Million-57.03%
2001 -NZ$0.7 Million1.03%
2000 -NZ$0.69 Million-53.22%
1999 -NZ$1.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.36 B 27,847.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.46 B 3,211.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.34 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.87 B 6,394.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel